Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
445.5 USD | +0.06% | +3.99% | +9.88% |
05-15 | Vertex Pharmaceuticals Incorporated Appoints Jennifer Schneider as Independent Director | CI |
05-14 | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.88% | 115B | |
+12.47% | 106B | |
-2.59% | 21.96B | |
-12.41% | 21.87B | |
-5.29% | 19.21B | |
-2.93% | 18.08B | |
-38.57% | 17.71B | |
+7.41% | 14.32B | |
+36.02% | 12.42B | |
-24.51% | 8.23B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Vertex Pharmaceuticals Insider Sold Shares Worth $6,973,945, According to a Recent SEC Filing